Technology

Aidoc Pioneers Next-Generation AI with CARE1™ Foundation Model, Revolutionizing CT Imaging Standards

Published

3 days ago

December 2, 2024

First application based on CARE1™ has been submitted for FDA review

NEW YORK, Dec. 2, 2024 /PRNewswire/ — Aidoc, the global leader in clinical AI, has developed CARE1™ (Clinical AI Reasoning Engine, Version 1), a groundbreaking clinical-grade foundation model for CT imaging, the first step in a multi-year investment in Aidoc’s Clinical AI Reasoning Engine (CARE™) framework. Trained on millions of exams and leveraging advanced multimodal capabilities, the CARE™ framework was developed to establish a new benchmark for precision and speed in developing clinical AI solutions. This innovation is designed to empower clinicians with unparalleled diagnostic accuracy and efficiency, unlocking AI’s full potential to tackle critical healthcare challenges by minimizing diagnostic delays, optimizing workflows and improving patient outcomes. CARE1™ is the culmination of relentless innovation, a bold vision and a significant investment of resources dedicated to this mission.

“Eighteen months ago, we embarked on an ambitious journey to redefine how clinical AI is developed and, in turn, how it serves healthcare,” said Michael Braginsky, CTO of Aidoc. “By unlocking new possibilities for AI, we aim to support clinicians in tackling complex challenges and help them set a new standard for patient care that the prior AI technologies couldn’t achieve. The CARE™ framework will gradually serve as the backbone of Aidoc’s AI solutions, enabling the development of versatile, high-performance AI capable of detecting a broad spectrum of critical conditions in real-time.”

Potential For Unmatched Accuracy Through Expertise, Scale and Innovation

What sets the CARE™ framework apart from other foundation models is its potential for unprecedented accuracy, with internal validations showing it may surpass the performance of Aidoc’s existing AI algorithms, which have already delivered proven clinical outcomes at scale. This breakthrough stems from a combination of unique factors:

Deep Clinical AI Expertise: With nearly a decade of experience in clinical AI and the largest install base in the industry, Aidoc has unparalleled experience in navigating the complexities of medical imaging. From managing missing or inconsistent data to addressing variability across diverse clinical settings, Aidoc has honed the ability to turn these challenges into opportunities, creating models that are not only accurate but also exceptionally robust.Purpose-Built Infrastructure: Aidoc’s advanced AI infrastructure has been meticulously developed to meet the demanding requirements of clinical-grade AI. Central to this is a robust validation framework, refined over years of building and deploying proven solutions in clinical settings. This framework ensures that every aspect of CARE1’s™ performance is rigorously tested and measured with precision. Aidoc focuses on rigorous internal validation for CARE1™ using a large, diverse dataset that reflects real-world clinical settings, ensuring reliable results. Significant Financial Investment: Delivering a foundation model of CARE1’s™ caliber required substantial investment. Aidoc’s strong financial backing enabled comprehensive data processing, extensive training, and rigorous testing, ensuring the delivery of this groundbreaking innovation at the highest level of quality and reliability.Unrivaled Data Scale: CARE1™ achieved groundbreaking results by training on a scale of data previously unattainable, spanning millions of cases across various conditions and anatomies. For the first time, this allowed a model to truly grasp the entire domain rather than focus on specific medical conditions, potentially unlocking unprecedented diagnostic power. Remarkably, this achievement leveraged only a fraction of Aidoc’s comprehensive dataset, underscoring the immense potential for further advancements.

By combining expertise, scale and innovation, CARE1™ is designed to redefine what’s possible in clinical AI and is well positioned to set a new benchmark for accuracy, versatility and reliability in healthcare diagnostics.

FDA Submission: A First Step Toward Transformative AI

As part of Aidoc’s commitment to robust and regulated AI, the company has already submitted its first real-world derivative of the CARE1™ Foundation Model for FDA 510(k) review. This initial application leveraged CARE1™ in Aidoc’s retrained rib fractures triage module with the addition of a pre-training layer. This submission reflects Aidoc’s approach to safely and rigorously transitioning to foundation model-based AI solutions in real-world clinical settings.

“We decided to start this shift by transforming the rib fractures triage module to be CARE1™-enabled, allowing us to begin learning how to measure, validate and ultimately bring foundation model-enabled algorithms to production in clinical settings,” added Braginsky. “This marks a pivotal shift in AI development at Aidoc. We’ve fully committed to foundation model technology because it’s clear this approach surpasses anything we’ve seen before. At the same time, we are steadfast in ensuring this transition is done with precision, focusing on safety, rigorous validation and a comprehensive understanding of this groundbreaking model’s behavior to ensure it delivers meaningful clinical impact.”

Shaping the Future of AI-Driven Healthcare

This breakthrough marks a transformative moment for Aidoc and the future of AI in medicine:

For AI Development: CARE™ framework will accelerate the creation of highly accurate models and enable entirely new applications, driving faster deployment to meet evolving healthcare needs.For AI Integration: As CARE™ framework and other foundation models enhance the ability to develop clinically meaningful AI modules, the challenge of their seamless integration into healthcare systems is increasing exponentially. This is especially true as the number of AI modules grows, making it harder to ensure they remain user friendly and harmonized. Aidoc’s aiOS™ platform provides health systems with the robust infrastructure needed to incorporate both Aidoc-developed and third-party AI models into sophisticated clinical workflows while maintaining usability and efficiency.

“The future of clinical AI is being reshaped by foundation models, which are set to revolutionize diagnostic workflows in healthcare. We’re encouraged to see the development of these transformative technologies by various leading players, as it underscores their immense potential,” said Elad Walach, CEO of Aidoc. “Ultimately, the true test of success lies in achieving the required accuracy for production-grade solutions. As we’ve all learned over the past decade of advancing clinical AI, the greatest challenge is delivering meaningful outcomes in real-world clinical settings. With CARE1™, Aidoc is just beginning to explore the immense possibilities that foundation models can unlock. Our mission has always been to empower providers to transform the core of diagnostic work, and CARE1™ is only the tip of the iceberg in an exciting journey toward delivering even greater value across the healthcare ecosystem.”

About Aidoc

Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Built on Aidoc’s proprietary aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (17) in clinical AI and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data. Visit Aidoc.com to see how we are connecting all points of care with always on AI.

Photo: https://mma.prnewswire.com/media/2570424/Aidoc.jpg
Logo: https://mma.prnewswire.com/media/2015772/5054067/Aidoc_Always_On_AI_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/aidoc-pioneers-next-generation-ai-with-care1-foundation-model-revolutionizing-ct-imaging-standards-302319664.html

SOURCE Aidoc

Technology

CJ 4DPLEX Appoints Jun Bang as New CEO

Published

8 minutes ago

December 5, 2024

Bang is the youngest ever CEO to be appointed within the CJ Group of Companies

SEOUL, South Korea and HOLLYWOOD, Calif., Dec. 4, 2024 /CNW/ — CJ 4DPLEX, the world’s leading producer of premium film formats and cinema technologies, announced today it has appointed Jun Bang as CEO. Bang is the youngest ever appointed CEO within the CJ Group of companies, also making him amongst the youngest executives to hold the position within Korea’s major conglomerate companies. His ascent at the company comes after the executive spearheaded several key initiatives and played a key role in the rapid success of the global entertainment company.

Bang was the key architect in building the company’s alternative content business. The company now produces and distributes nearly 20 original films a year, including various concert films of major Pop, K-Pop and J-Pop artists, and has also showcased the first theatrical live broadcast of sports in ScreenX, offering the Korean Baseball Organization’s playoff series in the multi-screen format early this fall.

He was also instrumental in building the ScreenX VFX Production and Creative Studio, which houses nearly 100 visual artists, and has allowed the ScreenX format to significantly increase its content slate to encompass all major Hollywood blockbusters as well as local tentpole projects in major global markets. Bang has also been a key executive, helping shape the company’s business strategy and growth by serving as a member of the executive management group of CJ CGV.

Bang most recently served as the COO of Content & Marketing where he headed original content investment, film and new media business operations, global marketing, and theatrical distribution at CJ 4DPLEX.

Bang has been with CJ 4DPLEX since 2018. Before leading the Content Division at CJ 4DPLEX, he was Senior Director, Content Business Innovation where he oversaw content investment and distribution strategies as well as ScreenX and 4DX studio operations. Prior to joining CJ, Bang served in roles spanning innovation strategy, new biz development and administration in various industries and markets.

“Transitioning into the role of CEO at CJ 4DPLEX, I am excited to lead the company in its next phase during a pivotal moment in cinematic entertainment,” said Jun Bang, CEO of CJ 4DPLEX. “With all the recent momentum our theaters have recently received, we will aggressively expand all facets of our operation as more and more moviegoers look to experience 4DX and ScreenX theaters around the world.”

Headquartered in Seoul, South Korea, CJ 4DPLEX operates revolutionary film technologies for theaters worldwide including the multi-sensory 4DX format and the panoramic ScreenX format. CJ 4DPLEX is part of the CJ Group conglomerate that also includes entertainment powerhouses CJ ENM and the fifth largest cinema chain in the world, CJ CGV. CJ 4DPLEX is a subsidiary of CJ CGV.

“We are thrilled Jun is taking the helm at CJ 4DPLEX at this exciting time for the company,” said Don Savant, CEO & President of CJ 4DPLEX America. “Jun’s leadership in developing alternative concert music content for global cinema and expanding our VFX studio to enhance our Hollywood and local productions has been a game changer for the cinema industry, which is fighting to differentiate cinema from home and streaming.”

As the world’s first multi-projection cinema, ScreenX is a cutting-edge cinematic technology that expands specially selected sequences of the film onto the left-and-right-side walls of the auditorium. The 270-degree field of view creates a virtual reality-like setting with cinema quality resolution. There are over 420 ScreenX auditoriums around the world in 40 countries.

4DX pushes the conventional boundaries of cinema by offering a multi-sensory experience, integrating motion-based seating synchronized with over 21 distinct effects. Through motion, vibration, water, wind, snow, lightning, scents, and various other special effects, 4DX’s state-of-the-art technology immerses audiences into the action of the film through these effects-enhancing features. To date, there are over 800 4DX auditoriums around the world, spanning over 70 countries.

About CJ 4DPLEX:

CJ 4DPLEX is a leading, next-generation cinema technology company, headquartered in Seoul with international offices in Los Angeles and Beijing. The company has created innovative film technologies for theaters worldwide that include ‘ScreenX’, ‘4DX’, and ‘Ultra 4DX’ for consumers to experience films in ways that were never before possible.

CJ 4DPLEX is a part of the CJ Group conglomerate that also includes entertainment powerhouses CJ CGV, the fifth largest theater chain in the world, and CJ ENM (CJ Entertainment & Media), who produced the Academy Award®, Golden Globe® and SAG Awards winning film, “Parasite”.

ScreenX is the world’s first multi-projection cinema with an immersive 270 degree field of view. By expanding the image beyond the frame and onto the walls of the theater, ScreenX places the audience directly at the center of the story, creating a visually immersive viewing experience unlike any other. To date, there are over 370 ScreenX auditoriums around the world in 40 countries.

4DX provides moviegoers with a multi-sensory cinema-going experience, allowing audiences to connect with movies through motion, vibration, water, wind, snow, lightning, scents, and other special effects that enhance the visuals on-screen. Each 4DX auditorium incorporates motion-based seating synchronized with more than 21 different effects and optimized by a team of skilled editors. To date, there are over 790 4DX auditoriums around the world, spanning over 70 countries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cj-4dplex-appoints-jun-bang-as-new-ceo-302323297.html

SOURCE CJ 4DPLEX

Technology

Binance Becomes the Official Gold Sponsor of Taipei Blockchain Week 2024

Published

8 minutes ago

December 5, 2024

TAIPEI, Dec. 5, 2024 /PRNewswire/ — Binance, the global blockchain ecosystem behind the largest cryptocurrency exchange by trading volume, is delighted to announce its return as the official Gold Sponsor of the 2024 Taipei Blockchain Week. Marking its third annual event, Taipei Blockchain Week is expected to attract over 6,000 participants from around the globe this year. Vishal Sacheendran, Binance’s Head of Regional Markets, will be making his first public appearance in Taiwan and speaking at the event.

Following an overwhelmingly positive feedback from the community last year, Binance will be returning to Taipei Blockchain Week, held next week from December 12 to 14. Vishal will be doing a fireside chat, where he will share insights on the driving force behind the market’s rally and the impact brought by latest regulatory development. Vishal, a former regulator who has been with Binance for nearly three years now, has represented the organization in many major events worldwide.

Join Binance at this premier event to explore the future of blockchain and virtual assets:

Topic: “The Golden Era of Crypto: What Can We Expect Next?” – a fireside chat with Vishal Sacheendran.Date: December 13, FridayTime: 13:10 – 13:35 (UTC+8)

Vishal Sacheendran expressed his excitement for the visit: “I am excited to visit Taiwan and to engage with other attendees during Taipei Blockchain Week. Meaningful engagements and discussions are important to foster healthy growth and adoption of blockchain technology, and I find that events like this offer a great platform to do just that. I am really looking forward to experiencing firsthand the vibrant Web3 community that Taiwan has to offer.”

By participating in this international event, Binance aims to bring its global industry experience to Taiwan, fostering meaningful dialogue and collaboration while also supporting the growth of Taiwan’s blockchain and crypto communities.

Attendees are also welcome to visit Binance’s booth, where they can connect with like-minded community members, volunteers, and blockchain enthusiasts. Limited-edition Binance souvenirs and swag will also be available at the booth.

About Binance
Binance is a leading global blockchain ecosystem behind the world’s largest cryptocurrency exchange by trading volume and registered users. Binance is trusted by more than 240 million people in 100+ countries for its industry-leading security, transparency, trading engine speed, protections for investors, and unmatched portfolio of digital asset products and offerings from trading and finance to education, research, social good, payments, institutional services, and Web3 features. Binance is devoted to building an inclusive crypto ecosystem to increase the freedom of money and financial access for people around the world with crypto as the fundamental means. For more information, visit: https://www.binance.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/binance-becomes-the-official-gold-sponsor-of-taipei-blockchain-week-2024-302322312.html

SOURCE Binance

Technology

AI-Powered Application Development Introduces New IT Challenges, According to OutSystems Study

Published

8 minutes ago

December 5, 2024

While 88% of IT professionals are exploring building GenAI-powered apps, security and governance concerns and talent shortages are stalling projects

SINGAPORE, Dec. 5, 2024 /PRNewswire/ — OutSystems, a global leader transforming how companies innovate through software, today released its global 2025 State of Application Development report, revealing the obstacles IT professionals face—as well as the innovative approaches they’re taking—when developing modern applications. Notably, the report, which reflects the perspectives of nearly 1,700 global IT professionals, found that the majority (81%) are using GenAI to assist with traditional coding, but also found that GenAI introduces security and governance concerns for 62% of respondents.

Across industries, IT teams are seeing high demand for applications. Nearly three-quarters (74%) of respondents say their organizations plan to build 10 or more apps over the next 12 months, while 45% anticipate building more than 25 apps over the same timeframe. Considering that 74% of organizations are planning to build external, customer-facing applications in the next year, the stakes are high.

“As enterprises are increasingly opting to build software rather than buy it, today’s developers are under immense pressure to deliver mission-critical, customer-facing apps at unprecedented speed,” said Paulo Rosado, CEO & Founder of OutSystems. “While GenAI is a powerful tool to increase productivity and develop code faster, AI-written code can lead to considerable security and governance issues if left unchecked, so IT leaders must consider ways to incorporate guardrails without stalling the speed of innovation.”

With considerable workloads, a persistent talent shortage, and high costs associated with traditional application development, it’s no surprise that developer teams are leaning on GenAI for support. However, half of IT professionals (50%) report significant complexities with integrating AI technologies with existing software development workﬂows, and only 40% of respondents “mostly” trust GenAI to write code without human assistance.

Relying solely on traditional coding is often too time, labor, and resource intensive for IT teams to keep up with an aggressive application development strategy, but GenAI may not be capable of fully taking the reins just yet. A study found that popular GenAI tools generate accurate code no more than approximately 65% of the time—with accuracy rates for some tools falling as low as 31%.

“In the Generative Software Cycle, we believe that GenAI and low-code in combination will redefine application development, increase productivity while ensuring governance throughout the entire software development lifecycle,” Rosado continued. “Developer teams shouldn’t have to choose between high-quality, fully functional apps and speed-to-market, and by abandoning antiquated development practices in favor of AI-powered low-code technology, they can reap the performance and agility benefits of these transformative technologies.”

Low-code development continues to be seen as predictable, productive, and cost-effective. Respondents with more mature low-code applications noted increased developer productivity (36%), faster time to market (34%), and ease of updating apps (32%) as key benefits to implementing low-code. Even further, 62% of organizations using low-code reported the ability to consistently predict budget compared to 52% of organizations using traditional code.

OutSystems recently unveiled OutSystems Mentor, a first-of-its-kind full software development lifecycle (SDLC) digital worker that enables app generation, delivery, and monitoring using low-code, GenAI, and AI-powered guidance. With Mentor, IT teams can generate fully functional, scalable apps in minutes—while maintaining control and governance throughout the SDLC. To learn more about how OutSystems Mentor helps organizations fully harness the potential of AI-driven software development, click here.

Survey Methodology

OutSystems and Centiment surveyed 1,666 global IT professionals in September 2024. Respondents held a range of positions within their organizations’ IT departments, with the majority in management or senior management. Their organizations report revenue ranging from under $10M to more than $2.5B, and have been in business between 1 and 20+ years.

For more key findings, as well as practical strategies for how IT leaders can use AI and low-code to lead in the evolving landscape of application development, read the full report here.

About OutSystems

OutSystems is a global leader transforming how companies innovate through software, empowering IT leaders with a better way to build the software that matters most. The OutSystems platform helps companies develop, deploy, and maintain mission-critical applications by unifying and automating the entire software lifecycle. With OutSystems, organizations leverage GenAI to deliver software instantaneously, adapt faster to changing requirements, and reduce technical debt by building on a future-proof platform. Helping customers achieve their business goals by addressing key strategic initiatives, OutSystems delivers software up to 10x faster than traditional development. Recognized as a leader by analysts, IT executives, business leaders, and developers around the world, global brands trust OutSystems to tackle their impossible projects and turn their big ideas into software that moves their business, people, and the world forward.

Founded in 2001, the company’s network spans more than 800,000 community members, over 500 partners, and active customers in 75+ countries across 21 industries. Learn more at www.outsystems.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ai-powered-application-development-introduces-new-it-challenges-according-to-outsystems-study-302322474.html

SOURCE OutSystems